Alkem Laboratories Community

NSEI:ALKEM Community

1 Narratives written by author
0 Comments on narratives written by author
3 Fair Values set on narratives written by author

Alkem Laboratories

AN

AnalystConsensusTarget

Consensus Narrative from 21 Analysts

Semaglutide Launch And Acquisitions In Cosmetology And Orthopedics Will Strengthen Future Market Position

Key Takeaways Strategic acquisitions and product launches, such as GLP-1 in India, will boost revenue growth and enhance market share in key therapeutic areas. Focus on higher-margin offerings and supply chain improvements in the U.S. aims to bolster EBITDA margins and stabilize earnings.

₹5.37k

FV

3.1% undervalued

9.61%

Revenue growth p.a.

0

0

0

Updated